JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB185238

Anti-VEGFA antibody [EP1176Y] - BSA and Azide free

5

(1 Review)

|

(16 Publications)

Rabbit Recombinant Monoclonal VEGFA antibody. Carrier free. Suitable for ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Mouse, Human samples. Cited in 16 publications.

View Alternative Names

VEGF, VEGFA, L-VEGF, Vascular permeability factor, VPF

9 Images
Immunocytochemistry/ Immunofluorescence - Anti-VEGFA antibody [EP1176Y] - BSA and Azide free (AB185238)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-VEGFA antibody [EP1176Y] - BSA and Azide free (AB185238)

Clone EP1176Y (ab185238) has been successfully conjugated by Abcam. This image was generated using Anti-VEGFA antibody [EP1176Y] (Alexa Fluor® 488). Please refer to ab206886 for protocol details.

ab206886 staining VEGF in HeLa (Human epithelial cell line from cervix adenocarcinoma) cells. The cells were fixed with 4% formaldehyde (10 minutes), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1 hour. The cells were then incubated overnight at +4°C with ab206886 at 1/1000 dilution (shown in green) and ab195889, Mouse monoclonal to alpha Tubulin (Alexa Fluor® 594), at 1/250 dilution (shown in red). Nuclear DNA was labelled with DAPI (shown in blue).

Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGFA antibody [EP1176Y] - BSA and Azide free (AB185238)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGFA antibody [EP1176Y] - BSA and Azide free (AB185238)

This data was developed using ab52917, the same antibody clone in a different buffer formulation.

Immunohistochemical analysis of formalin fixed paraffin embedded human kidney labelling VEGFA with ab52917 at a concentration of 2µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a ChromoMap DAB IHC Detection Kit followed by anti rabbit HQ and anti HQ HRP detection. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 64mins.

ab52917 Anti-VEGFA antibody [EP1176Y] was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.

Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGFA antibody [EP1176Y] - BSA and Azide free (AB185238)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGFA antibody [EP1176Y] - BSA and Azide free (AB185238)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human kidney tissue sections labeling VEGFA with Purified ab52917 at 1 : 100 dilution (2.96 µg/ml). Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0)

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab52917).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGFA antibody [EP1176Y] - BSA and Azide free (AB185238)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGFA antibody [EP1176Y] - BSA and Azide free (AB185238)

Immunohistochemistry (Paraffin-embedded sections) analysis of Human kidney tissue labeling VEGF with ab185238 at 1/250. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9.0. Anti-rabbit IgG H&L (HRP) (ab97051) was used as the secondary antibody. Counterstained with Hematoxylin.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab52917).

Flow Cytometry (Intracellular) - Anti-VEGFA antibody [EP1176Y] - BSA and Azide free (AB185238)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-VEGFA antibody [EP1176Y] - BSA and Azide free (AB185238)

Clone EP1176Y (ab185238) has been successfully conjugated by Abcam. This image was generated using Anti-VEGFA antibody [EP1176Y] (PE). Please refer to ab209439 for protocol details.

Overlay histogram showing HeLa cells stained with ab209439 (red line). The cells were fixed with 4% formaldehyde (10 min) and then permeabilized with 90% methanol at -20°C for 15 min. The cells were then incubated in 1x PBS / 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (ab209439, 1/2500 dilution) for 30 min at 22°C.Isotype control antibody (black line) was rabbit IgG (monoclonal) Phycoerythrin (ab209478) used at the same concentration and conditions as the primary antibody. Unlabelled sample (blue line) was also used as a control. Acquisition of >5,000 events were collected using a 20 mW Solid State Blue Laser (488nm) and 585/40 bandpass filter.

Immunocytochemistry/ Immunofluorescence - Anti-VEGFA antibody [EP1176Y] - BSA and Azide free (AB185238)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-VEGFA antibody [EP1176Y] - BSA and Azide free (AB185238)

Clone EP1176Y (ab185238) has been successfully conjugated by Abcam. This image was generated using Anti-VEGFA antibody [EP1176Y] (Alexa Fluor® 647). Please refer to ab206887 for protocol details.

ab206887 staining VEGF in HeLa cells. The cells were fixed with 4% formaldehyde (10 min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated overnight at +4°C with ab206887 at 1/100 dilution (shown in red) and ab195887, Mouse monoclonal to alpha Tubulin (Alexa Fluor® 488), at 1/250 dilution (shown in green). Nuclear DNA was labelled with DAPI (shown in blue).

Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).

Flow Cytometry (Intracellular) - Anti-VEGFA antibody [EP1176Y] - BSA and Azide free (AB185238)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-VEGFA antibody [EP1176Y] - BSA and Azide free (AB185238)

Intracellular Flow Cytometry analysis of NIH/3T3 (Mouse embryonic fibroblast) cells labeling VEGFA with purified ab52917 at 1/30 dilution (10 μg/ml) (red). Cells were fixed with 4% Paraformaldehyde. A Goat anti rabbit IgG (Alexa Fluor® 488) secondary antibody was used at 1/2000 dilution. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab52917).

Immunocytochemistry/ Immunofluorescence - Anti-VEGFA antibody [EP1176Y] - BSA and Azide free (AB185238)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-VEGFA antibody [EP1176Y] - BSA and Azide free (AB185238)

Purified ab52917 staining VEGF in NIH3T3 cells. The cells were fixed with 4% formaldehyde (10min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked in 1% BSA/10% normal goat serum/0.3M glycine in 0.1%PBS-Tween for 1h. The cells were then incubated with purified ab52917 at 5μg/ml and ab195884, at 1/250 dilution, overnight at +4°C, followed by a further incubation at room temperature for 1h with an Goat anti-Rabbit Alexa Fluor 488 secondary (ab150081) at 2 μg/ml (shown in green). Nuclear DNA was labelled in blue with DAPI.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab52917).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGFA antibody [EP1176Y] - BSA and Azide free (AB185238)
  • IHC-P

AbReview38570****

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-VEGFA antibody [EP1176Y] - BSA and Azide free (AB185238)

Unpurified ab52917 staining VEGF in Mouse kidney tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed with paraformaldehyde, permeabilized with 0.3% Triton X-100 and blocked with 5% serum for 45 minutes at 25°C. Samples were incubated with primary antibody (1/400 in 4% BSA + 5% serum in PBST) for 14 hours at 4°C. An Alexa Fluor® 546-conjugated Donkey anti-rabbit IgG polyclonal (1/300) was used as the secondary antibody.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab52917).

This image is courtesy of an anonymous Abreview.

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EP1176Y

Isotype

IgG

Carrier free

Yes

Reacts with

Mouse, Human

Applications

ICC/IF, Flow Cyt (Intra), IHC-P

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

We do not guarantee IHC-P for mouse.
This antibody fails to detect endogenous natural samples in WB. We recommend to use ab214424 for WB.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p>We do not guarantee IHC-P for mouse.</p>" }, "Mouse": { "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "<p><a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-low-endotoxin-azide-free-ab199376'>ab199376</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p>We do not guarantee IHC-P for mouse.</p>" }, "Rat": { "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "FlowCytIntra-species-checked": "notRecommended", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

Product details

ab185238 is the carrier-free version of ab52917.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.

Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.

Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Do Not Freeze

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Vascular endothelial growth factor A (VEGFA) also known as VEGF or vascular permeability factor (VPF) is a protein that plays a central role in angiogenesis as well as in the growth of blood vessels. The molecular weight of VEGFA varies depending on the isoform typically ranging from 34 to 42 kDa. VEGFA is expressed in many tissues including fibroblasts macrophages endothelial cells and platelets. Its expression levels can increase in response to stimuli like hypoxia or inflammatory cytokines. VEGFA is an important target in research for therapies related to vascular diseases and cancer.
Biological function summary

VEGFA functions by promoting the proliferation and migration of vascular endothelial cells. It operates both as a homodimer and as part of complex signaling cascades interacting with VEGF receptors on cell surfaces to trigger downstream signals for angiogenesis. This includes endothelial cell growth migration and the new blood vessel formation process. VEGFA's activity is important for physiological processes such as wound healing and embryonic development and it also contributes to pathological conditions through its unregulated expression in diseases.

Pathways

Many processes involve VEGFA including the PI3K/AKT pathway and the MAPK/ERK pathway. These pathways regulate cell survival growth and differentiation. Other proteins like PLGF (placenta growth factor) and VEGFB often accompany VEGFA in these pathways aiding in distinct but overlapping roles. These interactions are transmitted through binding to VEGF receptors such as VEGFR-1 and VEGFR-2 subsequently activating various signaling cascades necessary for cellular and tissue homeostasis.

VEGFA relates to cancer and age-related macular degeneration among others. In cancer overexpression of VEGFA can lead to excessive angiogenesis supplying blood to tumors and facilitating tumor growth. In age-related macular degeneration upregulation of VEGFA contributes to the progression of the disease by promoting the formation of abnormal blood vessels under the retina. Anti-VEGFA therapies such as anti-VEGF antibodies (e.g. bevacizumab) can target these overexpressed pathways. VEGFA interacts with other proteins like HIF-1α which regulates its expression under hypoxia a common condition in tumors.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

N-VEGF. Participates in the induction of key genes involved in the response to hypoxia and in the induction of angiogenesis such as HIF1A (PubMed : 35455969). Involved in protecting cells from hypoxia-mediated cell death (By similarity).. VEGFA. Growth factor active in angiogenesis, vasculogenesis and endothelial cell growth (PubMed : 34530889). Induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels. Binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin. Binds to the NRP1/neuropilin-1 receptor. Binding to NRP1 initiates a signaling pathway needed for motor neuron axon guidance and cell body migration, including for the caudal migration of facial motor neurons from rhombomere 4 to rhombomere 6 during embryonic development (By similarity). Also binds the DEAR/FBXW7-AS1 receptor (PubMed : 17446437).. Isoform VEGF165B. Binds to the KDR receptor but does not activate downstream signaling pathways, does not activate angiogenesis and inhibits tumor growth.
See full target information VEGFA

Publications (16)

Recent publications for all applications. Explore the full list and refine your search

iScience 28:112862 PubMed40612503

2025

Syndecan-1-mediated loading of VEGF-A into small extracellular vesicles facilitates peritubular capillary repair during AKI-to-CKD transition.

Applications

Unspecified application

Species

Unspecified reactive species

Xin Zhong,Tao-Tao Tang,Yue Zhang,Ding-Ding Xue,An-Ran Shen,Ning Li,Min Wu,Bi-Cheng Liu,Lin-Li Lv

European journal of dentistry 19:531-539 PubMed39657933

2024

The Expression of HIF-1α and VEGF in Radicular Cysts and Periapical Granulomas.

Applications

Unspecified application

Species

Unspecified reactive species

Mohammed Amjed Alsaegh,Shishir Ram Shetty,Okba Mahmoud,Sudhir Rama Varma,Alaa Muayad Altaie,Surendra Singh Rawat

Biomedicines 12: PubMed39200306

2024

Characterization of the Secretome from Spheroids of Adipose-Derived Stem Cells (SASCs) and Its Potential for Tissue Regeneration.

Applications

Unspecified application

Species

Unspecified reactive species

Valentina Urrata,Francesca Toia,Emanuele Cammarata,Mara Franza,Luigi Montesano,Adriana Cordova,Anna Barbara Di Stefano

Cancer cell 42:1217-1238.e19 PubMed38981438

2024

Multi-scale signaling and tumor evolution in high-grade gliomas.

Applications

Unspecified application

Species

Unspecified reactive species

Jingxian Liu,Song Cao,Kathleen J Imbach,Marina A Gritsenko,Tung-Shing M Lih,Jennifer E Kyle,Tomer M Yaron-Barir,Zev A Binder,Yize Li,Ilya Strunilin,Yi-Ting Wang,Chia-Feng Tsai,Weiping Ma,Lijun Chen,Natalie M Clark,Andrew Shinkle,Nataly Naser Al Deen,Wagma Caravan,Andrew Houston,Faria Anjum Simin,Matthew A Wyczalkowski,Liang-Bo Wang,Erik Storrs,Siqi Chen,Ritvik Illindala,Yuping D Li,Reyka G Jayasinghe,Dmitry Rykunov,Sandra L Cottingham,Rosalie K Chu,Karl K Weitz,Ronald J Moore,Tyler Sagendorf,Vladislav A Petyuk,Michael Nestor,Lisa M Bramer,Kelly G Stratton,Athena A Schepmoes,Sneha P Couvillion,Josie Eder,Young-Mo Kim,Yuqian Gao,Thomas L Fillmore,Rui Zhao,Matthew E Monroe,Austin N Southard-Smith,Yang E Li,Rita Jui-Hsien Lu,Jared L Johnson,Maciej Wiznerowicz,Galen Hostetter,Chelsea J Newton,Karen A Ketchum,Ratna R Thangudu,Jill S Barnholtz-Sloan,Pei Wang,David Fenyö,Eunkyung An,Mathangi Thiagarajan,Ana I Robles,D R Mani,Richard D Smith,Eduard Porta-Pardo,Lewis C Cantley,Antonio Iavarone,Feng Chen,Mehdi Mesri,MacLean P Nasrallah,Hui Zhang,Adam C Resnick,Milan G Chheda,Karin D Rodland,Tao Liu,Li Ding

Cancer cell international 24:195 PubMed38835070

2024

YTHDF1's grip on CRC vasculature: insights into LINC01106 and miR-449b-5p-VEGFA axis.

Applications

Unspecified application

Species

Unspecified reactive species

Rui-Ting Ma,Yuanyuan Wang,Feng Ji,Jian-Nan Chen,Tian-Jun Wang,Yan Liu,Ming-Xing Hou,Zhi-Gang Guo

Science advances 10:eadi5501 PubMed38354243

2024

Nanoparticle-based inhibition of vascular endothelial growth factor receptors alleviates osteoarthritis pain and cartilage damage.

Applications

Unspecified application

Species

Unspecified reactive species

Kaige Ma,Tiep Pham,Jun Wang,InSug O-Sullivan,Amy DiCamillo,Shiyu Du,Fackson Mwale,Zeba Farooqui,Gina Votta-Velis,Benjamin Bruce,Andre J van Wijnen,Ying Liu,Hee-Jeong Im

Physiological reports 11: PubMed37962017

2023

The effects of treadmill exercise on brain angiogenesis in ovariectomized rats.

Applications

Unspecified application

Species

Unspecified reactive species

Eun-Jung Yoon,Jiwon Jeong,Eunji Yoon,Dongsun Park

Gene 878:147578 PubMed37336277

2023

Spheroids of adipose derived stem cells show their potential in differentiating towards the angiogenic lineage.

Applications

Unspecified application

Species

Unspecified reactive species

Anna Barbara Di Stefano,Francesca Toia,Valentina Urrata,Marco Trapani,Luigi Montesano,Emanuele Cammarata,Francesco Moschella,Adriana Cordova

International journal of biological sciences 19:675-690 PubMed36632459

2023

Targeting Vascular Endothelial Growth Factor Receptors as a Therapeutic Strategy for Osteoarthritis and Associated Pain.

Applications

Unspecified application

Species

Unspecified reactive species

Kaige Ma,Gurjit Singh,Jun Wang,InSug O-Sullivan,Gina Votta-Velis,Benjamin Bruce,Arivarasu Natarajan Anbazhagan,Andre J van Wijnen,Hee-Jeong Im

Stem cells international 2022:9806887 PubMed36199627

2022

Erythropoietin Activates Autophagy to Regulate Apoptosis and Angiogenesis of Periodontal Ligament Stem Cells via the Akt/ERK1/2/BAD Signaling Pathway under Inflammatory Microenvironment.

Applications

Unspecified application

Species

Unspecified reactive species

Denghao Huang,Jie Lei,Xingrui Li,Zhonghao Jiang,Maoxuan Luo,Yao Xiao
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com